Clinical Oncology - 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Future perspectives in breast cancer treatment, highlights of the 45th San Antonio Breast Cancer Symposium]

VAJDICS Tímea

[The SABCS (San Antonio Breast Cancer Symposium) is one of the most prestigious oncology events, which was held in the USA for the 45th time in 2022.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Cancer pain relief. Efficacy and safety]

SIMKÓ Csaba

[The author presents the most important steps of pain analysis, emphasizing the importance of bedside sensory testing in the recognition of neuropathic pain components.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Non-small cell lung cancer as a curable disease?]

OSTOROS Gyula, BOGOS Krisztina, BERTA Judit

[The complex therapeutic strategy for non-small cell lung cancer (NSCLC) has changed significantly in recent years. With the perioperative use of immuno- and chemotherapy or targeted therapies, disease-free survival has been significantly increased. In oncogene addictive metastatic NSCLC, the range of targeted therapeutic options is expanding significantly, the expected overall survival is measured in years. In the case of non-oncogene addictive metastatic NSCLC the new immune- and chemotherapy clinical trials have demonstrated a 5-year survival rate of almost 20%. In the light of these data, it can be stated that lung cancer can no longer be considered as a stigma. There is a chance that this cancer, with a poor prognosis previously, will become a chronic disease, even in stage IV lung cancer, with an active tumour control over the years. Complete recovery is nowadays still predominantly expected in patients who underwent ablastic pulmonary resection discovered in early stage, but it can also be a reality in locally
advanced stages using the combination of radio-chemotherapy and immunotherapy.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Cancer pain relief. Efficacy and safety]

SIMKÓ Csaba

[The author presents the most important steps of pain analysis, emphasizing the importance of bedside sensory testing in the recognition of neuropathic pain components.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials]

PEREZ-GRACIA JL, PENEL N, CALVO E, AWADA A, ARKENAU HT, AMARAL T, GRÜNWALD V, SANMAMED MF, CASTELO-BRANCO L, BODOKY G, LOLKEMA MP, DI NICOLA M, CASALI P, GIULIANI R, PENTHEROUDAKIS G

[During recent years, the burden of bureaucracy in clinical research has increased dramatically, adversely impacting the activity of investigators and clinical research teams.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[The significance of tumor microenvironment (stroma)]

KOVALSZKY Ilona

[Similarly to our healthy organs, tumor tissue also creates an ecosystem. ]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[Aspects of psycho-oncological treatment in the case of male patients fighting urological cancer]

KOVÁCS Ágnes Anna, BERTA Tibor, FEDOR Mariann, BENKŐ Henrietta

[The present review aims to summarize the characteristics of the psyco-oncological support of male patients suffering from uro-oncological diseases as well as the typical problems that hinder their efficient psycho-oncological care.]

HUN 2023;10(1)

Clinical Oncology

FEBRUARY 28, 2023

[The role of the microbiome in colorectal cancer development]

SCHWAB Richard, BÁN Orsolya, DARIDA-SÁRKÖZI Anita, VÁRKONDI Edit, DÉRI Júlia, LENGYEL Erzsébet, PAJKOS Gábor, URBÁN László, BAFFY György, PETÁK István

[In relation to microbiome-associated diseases, we have witnessed an explosive development in the past 10 years. More and more metabolic and inflammatory diseases of previously unknown origin have been found to belong here, and their pathomechanism has been clarified - and now tumours are starting to catch up as well.]

HUN 2023;10(1)